These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1249 related articles for article (PubMed ID: 4133186)

  • 1. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective tumour chemotherapy using oncobiograms (author's transl)].
    Volm M; Kaufmann M; Wayss K; Goerttler K; Mattern J
    Dtsch Med Wochenschr; 1974 Jan; 99(2):38-43. PubMed ID: 4129485
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale of combination chemotherapy based on preclinical experiments.
    Goldin A
    Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
    [No Abstract]   [Full Text] [Related]  

  • 5. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical aspects of drug combinations.
    Brockman RW
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 10. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer and the lymphatic system].
    Grekh IF
    Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern methods of therapeutic management of malignant proliferative disorders].
    Sroczyński J
    Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Augmentation of antitumor immunity in cancer chemotherapy].
    Hosokawa M; Kobayashi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A review of clinical tumor immunology. An approach to immunochemotherapy].
    Hattori T
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):381-90. PubMed ID: 4616062
    [No Abstract]   [Full Text] [Related]  

  • 15. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination cancer therapy: Presidential address.
    Frei E
    Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.
    Mihich E
    Natl Cancer Inst Monogr; 1971 Dec; 34():90-102. PubMed ID: 4400958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy for spontaneous AKR lymphoma.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Cheeks JB
    Cancer Chemother Rep 2; 1974 Mar; 4(1):53-72. PubMed ID: 4499910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 63.